Ventilator-associated pneumonia in the ICU

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Kalanuria, Atul A ^a   Zai, Wendy ^b   Mirski, Marek ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFUROXIME; CHLORHEXIDINE; COLISTIN; ERTAPENEM; MOXIFLOXACIN; POLYMYXIN B; QUINOLONE DERIVATIVE; SULTAMICILLIN;

ACINETOBACTER; ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL VIRULENCE; CLINICAL PULMONARY INFECTION SCORE; DISEASE SEVERITY; ENTEROBACTER; ESCHERICHIA COLI; GOLD STANDARD; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; META ANALYSIS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOUTH HYGIENE; MUCOCILIARY CLEARANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; SERRATIA MARCESCENS; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TREATMENT DURATION; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; ADVERSE EFFECTS; ARTIFICIAL VENTILATION; CROSS INFECTION; PNEUMONIA, VENTILATOR-ASSOCIATED; TRENDS;

CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL;

EID: 84897410427     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13775     Document Type: Review

References (49)

1. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. American Thoracic Society, Infectious Diseases Society of America.
2. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995, 274:639-644. 10.1001/jama.1995.03530080055041, 7637145.
3. Chastre J, Fagon JY. State of the art: ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903. 10.1164/ajrccm.165.7.2105078, 11934711.
4. Hunter JD. Ventilator associated pneumonia. BMJ 2012, 344:e3325. 10.1136/bmj.e3325, 22645207.
5. Afshari A, Pagani L, Harbarth S. Year in review 2011: Critical care - infection. Crit Care 2012, 16:242-247. 10.1186/cc11421, 3672546, 23256824.
6. Skrupky LP, McConnell K, Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians Criteria. Crit Care Med 2012, 40:281-284. 10.1097/CCM.0b013e31822d7913, 21926609.
7. Rello J, Ollendorf D, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH, VAP Outcomes Scientific Advisory Group Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121. 10.1378/chest.122.6.2115, 12475855, VAP Outcomes Scientific Advisory Group.
8. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Int Med 1998, 129:433-440. 10.7326/0003-4819-129-6-199809150-00002, 9735080.
9. Melsen WG, Rovers MM, Koeman M, Bonten MJM. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med 2011, 39:2736-2742.
10. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M, Krueger WA, Lacherade JC, Lorente L, Memish ZA, Morrow LE, Nardi G, van Nieuwenhoven CA, O'Keefe GE, Nakos G, Scannapieco FA, Sequin P, Staudinger T, Topeli A, Ferrer M, Bonten MJ. Attributable mortality of ventilator-associated pneumonia: a meta¬analysis of individual patient data from randomised prevention studies. Lancet infect Dis 2013, 13:665-671. 10.1016/S1473-3099(13)70081-1, 23622939.
11. Zolfaghari PS, Wyncoll DL. The tracheal tube: gateway to ventilator-associated pneumonia. Crit Care 2011, 15:310-317. 10.1186/cc10352, 3334734, 21996487.
12. Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin infect Dis 2013, 26:140-150. 10.1097/QCO.0b013e32835ebbd0, 23411419.
13. Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care 2013, 58:990-1007. 10.4187/respcare.02380, 23709196.
14. Rocha LA, Marques Ribas R, da Costa Darini AL, Gontijo Filho PP. Relationship between nasal colonization and ventilator-associated pneumonia and the role of the environment in transmission of Staphylococcus aureus in intensive care units. Am J infect Control 2013, 41:1236-1240. 10.1016/j.ajic.2013.04.009, 23890377.
15. Morris AC, Brittan M, Wilkinson TS, McAuley DF, Antonelli J, McCulloch C, Barr LC, McDonald NA, Dhaliwal K, Jones RO, Mackellar A, Haslett C, Hay AW, Swann DG, Anderson N, Laurenson IF, Davidson DJ, Rossi AG, Walsh TS, Simpson AJ. C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 2011, 117:5178-5188. 10.1182/blood-2010-08-304667, 21292772.
16. Conway Morris A, Anderson N, Brittan M, Wilkinson TS, McAuley DF, Antonelli J, McCulloch C, Barr LC, Dhaliwal K, Jones RO, Haslett C, Hay AW, Swann DG, Laurenson IF, Davidson DJ, Rossi AG, Walsh TS, Simpson AJ. Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients. Br J Anaesth 2013, 3:1-10.
17. National Healthcare Safety Network (NHSN) July 2013 CDC/NHSN Protocol Clarifications. 2013, Accessed Oct 2013., http://www.cdc.gov/nhsn/PDFs/pscManual/10-VAE_FINAL.pdf
18. Klompas M, Clinician's Corner Does this patient have ventilator-associated pneumonia?. JAMA 2013, 297:1583-1593. Clinician's Corner.
19. Petersen IS, Aru A, Skødt V, Behrendt N, Bols B, Kiss K, Simonsen K. Evaluation of pneumonia diagnosis in intensive care patients. Scand J infect Dis 1999, 31:299-303. 10.1080/00365549950163617, 10482061.
20. Fabregas N, Ewig S, Torres A, Al-Abiary M, Ramirez J, de La Bellacasa JP, Bauer T, Cabello H. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54:867-873. 10.1136/thx.54.10.867, 1745365, 10491448.
21. Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann int Med 1972, 77:701-706. 10.7326/0003-4819-77-5-701, 5081492.
22. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic " blind" bronchoalveolar lavage fluid. Am RevRespirDis 1991, 143:1121-1129.
23. Shan J, Chen HL, Zhu JH. Diagnostic accuracy of clinical pulmonary infection score for ventilator-associated pneumonia: a meta-analysis. Respir Care 2011, 56:1087-1094. 10.4187/respcare.01097, 21310117.
24. Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin infect Dis 2010, 1:S131-S135.
25. Shorr AF, Cook D, Jiang X, Muscedere J, Heyland D. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 2008, 23:64-73. 10.1016/j.jcrc.2007.11.010, 18359423.
26. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511. 10.1164/ajrccm.162.2.9909095, 10934078.
27. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann intern Med 2000, 132:621-630.
28. Canadian Critical Care Trials Group A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2013, 355:2619-2630. Canadian Critical Care Trials Group.
29. Berton DC, Kalil AC, Cavalcanti M, Teixeira PJ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia Chocrane Database Syst Rev CD006482. 2012,
30. Klompas M. Complications of mechanical ventilation - the CDC's new surveillance paradigm. N Engl J Med 2013, 368:1472-1475. 10.1056/NEJMp1300633, 23594002.
31. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, Paterson DL. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin infect Dis 2013, 56:471-477. 10.1093/cid/cis926, 23118272.
32. Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Pollock DA, Edwards JR. National Healthcare Safety Network (NHSN) Report, data summary for 2010 device-associated module. Am J infect Control 2011, 39:798-816. 10.1016/j.ajic.2011.10.001, 22133532.
33. Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011, 27:149-162. 10.1016/j.ccc.2010.09.009, 21144991.
34. Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. intensive Care Med 2009, 35:9-29. 10.1007/s00134-008-1336-9, 18989656.
35. Walkey AJ, O'Donnell MR, Wiener RS. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest 2011, 139:1148-1155. 10.1378/chest.10-1556, 3087458, 20864609.
36. Munoz-Price LS, Weinstein RA. Acinetobacter Infection. N Engl J Med 2008, 358:1271-1281. 10.1056/NEJMra070741, 18354105.
37. Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, Niderman MS, Rello J, EU-VAP Study Investigators Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 2013, 39:672-681. 10.1007/s00134-012-2808-5, 23358539, EU-VAP Study Investigators.
38. Pasquale TR, Jabrocki B, Salstrom SJ, Wiemken TL, Peyrani P, Hague NZ, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, File TM, IMPACT-HAP Study Group Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. Inf J infect Dis 2013, 17:e398-e403. IMPACT-HAP Study Group.
39. Capellier G, Mockly H, Charpentier C, Annane D, Blasco G, Desmettre T, Roch A, Faisy C, Cousson J, Limat S, Mercier M, Papazian L. Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS one 2012, 7:e41290. 10.1371/journal.pone.0041290, 3432026, 22952580.
40. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, PneumA Trial Group Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290:2588-2598. 10.1001/jama.290.19.2588, 14625336, PneumA Trial Group.
41. Dimopoulos G, Poulakou G, Pneumatikos IA, Armaganidis A, Kollef MH, Matthaiou DK. Short-versus long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013, 144:1759-1767. 10.1378/chest.13-0076, 23788274.
42. Swoboda SM, Dixon T, Lipsett PA. Can the clinical pulmonary infection score impact ICU antibiotic days?. Surg infect (Larchmt) 2006, 7:331-339. 10.1089/sur.2006.7.331, 16978076.
43. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, Brooks O, Laurenson IF, Cook B, Walsh TS. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med 2011, 39:2218-2224. 10.1097/CCM.0b013e3182227d52, 21666444.
44. Alhazzani W, Almasoud A, Jaeschke R, Lo BW, Sindi A, Altayyar S, Fox-Robichaud A. Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 2013, 17:R127. 10.1186/cc12806, 23820047.
45. Muscedere J, Rewa O, McKechnie K, Jiang X, Laporta D, Heyland DK. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med 2011, 39:1985-1991. 10.1097/CCM.0b013e318218a4d9, 21478738.
46. Morrow LE, Kollef MH. Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med 2010, 38:S352-S362.
47. Youngquist P, Carroll M, Farber M, Macy D, Madrid P, Ronning J, Susag A. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 2007, 33(21):9-225.
48. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: Ventilator bundle as an example. Crit Care Med 2009, 37:305-309. 10.1097/CCM.0b013e3181926623, 19050626.
49. Vallés J, Peredo R, Burgueño MJ, Rodrigues de Freitas AP, Millán S, Espasa M, Martín-Loeches I, Ferrer R, Suarez D, Artigas A. Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated. Chest 2013, 143:1219-1225. 10.1378/chest.12-1361, 23715136.